EA200100638A1 - Ингибиторы герпесвирусов на основе альфа-метилбензил-содержащей тиомочевины, включающие фенилендиаминогруппу - Google Patents

Ингибиторы герпесвирусов на основе альфа-метилбензил-содержащей тиомочевины, включающие фенилендиаминогруппу

Info

Publication number
EA200100638A1
EA200100638A1 EA200100638A EA200100638A EA200100638A1 EA 200100638 A1 EA200100638 A1 EA 200100638A1 EA 200100638 A EA200100638 A EA 200100638A EA 200100638 A EA200100638 A EA 200100638A EA 200100638 A1 EA200100638 A1 EA 200100638A1
Authority
EA
Eurasian Patent Office
Prior art keywords
carbon atoms
alkyl
sor
cor
aryl
Prior art date
Application number
EA200100638A
Other languages
English (en)
Other versions
EA004205B1 (ru
Inventor
Джонатан Дэвид Блум
Кевин Джозеф Каррэн
Мартин Джозеф Дигранди
Расселл Джордж Дашин
Стэнли Альберт Лэнг
Эмили Бучер Нортон
Эдма Антониа Росс
Брайан Марк О'Хара
Original Assignee
Американ Хоум Продактс Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Американ Хоум Продактс Корпорейшн filed Critical Американ Хоум Продактс Корпорейшн
Publication of EA200100638A1 publication Critical patent/EA200100638A1/ru
Publication of EA004205B1 publication Critical patent/EA004205B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/84Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D307/85Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04Derivatives of thiourea
    • C07C335/16Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

Соединения, имеющие формулу (I), где R-Rнезависимо выбраны из водорода, алкила с 1-6 атомами углерода, алкенила с 2-6 атомами углерода, алкинила с 2-6 атомами углерода, пергалогеналкила с 1-6 атомами углерода, циклоалкила с 3-10 атомами углерода, гетероциклоалкила с 3-10 углеродными членами, арила, гетероарила, галогена, -CN, -NO, -COR, -COR, -OR, -SR, -SOR, -SOR, -CONRR, -NRN(RR), -N(RR) или W-Y-(CH)-Z при условии, что, по меньшей мере, один из R-Rне является водородом; или Rи Rлибо Rи R, взятые вместе, образуют (3-7)-членный гетероциклоалкил или (3-7)-членный гетероарил; Rи Rнезависимо представляют водород, алкил с 1-6 атомами углерода, пергалогеналкил с 1-6 атомами углерода или арил; Rпредставляет водород, алкил с 1-6 атомами углерода, пергалогеналкил с 1-6 атомами углерода, циклоалкил с 3-10 атомами углерода, гетероциклоалкил с 3-10 членами, арил или гетероарил, или Rи R, взятые вместе, могут образовывать (3-7)-членный гетероциклоалкил; W представляет O, NRили отсутствует; Y представляет -(CO)- или -(CO)- или отсутствует; Z представляет алкил с 1-4 атомами углерода, -CN, -COR, -COR, -CONRR, -OCOR, -NRCOR, -OCONR, -OR, -SR, -SOR, -SOR, -NRN(RR), -N(RR) или фенил; G представляет арил или конденсированный бициклический гетероарил; Х представляет связь, -NH, алкил с 1-6-атомами углерода, алкенил с 2-6 атомами углерода, алкокси с 1-6 атомами углерода, тиоалкил с 1-6 атомами углерода, алкиламино с 1-6 атомами углерода или (CH)J; J представляет алкил с 1-6 атомами углерода, циклоалкил с 3-7 атомами углерода, фенил или бензил; и n равно целому числу от 1 до 6; полезные при лечении заболеваний, связанных с вирусами герпеса, включая цитомегаловирус человека, вирус простого герпеса, вирус Эпштейн-Барра, вирус ветряной оспы, герпесвирусы-6 и -7 человека и герпесвирус Капози.Отчет о международном поиске был опубликован 2000.09.08.
EA200100638A 1998-12-09 1999-12-06 Ингибиторы герпесвирусов на основе альфа-метилбензилсодержащей тиомочевины, включающие фенилендиаминогруппу EA004205B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20890298A 1998-12-09 1998-12-09
PCT/US1999/028839 WO2000034260A2 (en) 1998-12-09 1999-12-06 Alpha-methylbenzyl-containing thiourea inhibitors of herpes viruses containing a phenylenediamine group

Publications (2)

Publication Number Publication Date
EA200100638A1 true EA200100638A1 (ru) 2001-12-24
EA004205B1 EA004205B1 (ru) 2004-02-26

Family

ID=22776519

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100638A EA004205B1 (ru) 1998-12-09 1999-12-06 Ингибиторы герпесвирусов на основе альфа-метилбензилсодержащей тиомочевины, включающие фенилендиаминогруппу

Country Status (21)

Country Link
EP (1) EP1137645B1 (ru)
JP (1) JP2002531555A (ru)
KR (1) KR20010089551A (ru)
CN (1) CN1165531C (ru)
AR (1) AR035308A1 (ru)
AT (1) ATE267824T1 (ru)
AU (1) AU1934600A (ru)
BR (1) BR9916084A (ru)
CA (1) CA2350833A1 (ru)
CZ (1) CZ20012067A3 (ru)
DE (1) DE69917673T2 (ru)
DK (1) DK1137645T3 (ru)
EA (1) EA004205B1 (ru)
ES (1) ES2221470T3 (ru)
HU (1) HUP0104492A3 (ru)
IL (1) IL143183A0 (ru)
NO (1) NO20012833L (ru)
NZ (1) NZ512135A (ru)
PT (1) PT1137645E (ru)
WO (1) WO2000034260A2 (ru)
ZA (1) ZA200104376B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844367B1 (en) 1999-09-17 2005-01-18 Millennium Pharmaceuticals, Inc. Benzamides and related inhibitors of factor Xa
ES2254385T3 (es) 2000-02-29 2006-06-16 Millennium Pharmaceuticals, Inc. Benzamidas e inhibidores relacionados del factor xa.
DE60133743T2 (de) * 2000-08-21 2009-07-02 Pacific Corp. Neue thiourea-derivate und pharmazeutische zusammensetzungen die diese enthalten
JP4360885B2 (ja) 2003-11-28 2009-11-11 富士フイルム株式会社 アルキルチオ基を有する芳香族アミン化合物の製造方法
CA2619366A1 (en) * 2005-08-22 2007-03-01 Amgen Inc. Bis-aryl urea compounds for the treatment of protein kinase-mediated diseases
WO2008057972A1 (en) 2006-11-02 2008-05-15 Millennium Pharmaceuticals, Inc. Methods of synthesizing pharmaceutical salts of a factor xa inhibitor
CN112807294B (zh) * 2019-11-18 2023-09-05 武汉大学 一种酰基硫脲类化合物在制备治疗或预防单纯疱疹病毒i型感染药物中的应用
CN115433093A (zh) * 2022-09-26 2022-12-06 无锡双启科技有限公司 一种3-氯-4-三氟甲基苯胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU210683B (en) * 1990-06-18 1995-06-28 Sandoz Ag Process for producing n-benzyl-n1-(phenyl-alkyl)-thiourea derivatives and pharmaceutical compositions containing the same
EP0809492A4 (en) * 1995-02-17 2007-01-24 Smithkline Beecham Corp IL-8 RECEPTOR ANTAGONISTS
GB9519270D0 (en) * 1995-09-21 1995-11-22 Sandoz Pharma Uk Organic compounds
CZ298463B6 (cs) * 1996-04-23 2007-10-10 Vertex Pharmaceuticals Incorporated Deriváty mocoviny pro použití jako inhibitory IMPDH enzymu a farmaceutické prostredky, které je obsahují

Also Published As

Publication number Publication date
HUP0104492A3 (en) 2002-12-28
CA2350833A1 (en) 2000-06-15
PT1137645E (pt) 2004-09-30
ATE267824T1 (de) 2004-06-15
DE69917673T2 (de) 2005-06-09
BR9916084A (pt) 2001-09-04
KR20010089551A (ko) 2001-10-06
DE69917673D1 (de) 2004-07-01
HUP0104492A2 (hu) 2002-04-29
NO20012833D0 (no) 2001-06-08
WO2000034260A3 (en) 2000-09-08
JP2002531555A (ja) 2002-09-24
WO2000034260A2 (en) 2000-06-15
NZ512135A (en) 2003-12-19
AR035308A1 (es) 2004-05-12
CN1329608A (zh) 2002-01-02
ZA200104376B (en) 2002-08-28
DK1137645T3 (da) 2004-08-09
EP1137645A2 (en) 2001-10-04
CZ20012067A3 (cs) 2001-10-17
CN1165531C (zh) 2004-09-08
ES2221470T3 (es) 2004-12-16
NO20012833L (no) 2001-08-02
EP1137645B1 (en) 2004-05-26
EA004205B1 (ru) 2004-02-26
AU1934600A (en) 2000-06-26
IL143183A0 (en) 2002-04-21

Similar Documents

Publication Publication Date Title
CA2282585A1 (en) Pyrazine compounds
EA200100640A1 (ru) Ингибиторы вирусов герпеса, представляющие собой ацетамид и замещенные ацетамидосодержащие тиомочевины
EA200100638A1 (ru) Ингибиторы герпесвирусов на основе альфа-метилбензил-содержащей тиомочевины, включающие фенилендиаминогруппу
EA200100634A1 (ru) Тиомочевинные ингибиторы вирусов герпеса
EA200100631A1 (ru) Ингибиторы вирусов герпеса, представляющие собой гетероциклические карбоксамидсодержащие тиомочевины, имеющие фенилендиаминогруппу
EA200100637A1 (ru) Ингибиторы вирусов герпеса на основе тиомочевины
EA200100639A1 (ru) Производные тиомочевины, содержащие гетероциклический карбоксамид и защитную группу фенилэтиленамина, в качестве ингибиторов вирусов герпеса
EA200100635A1 (ru) Производные тиомочевины в качестве ингибиторов вирусов герпеса
EA199800527A1 (ru) Производнфе 2-амино-5,6-дихлорбензимидазола, обладающие противовирусной активностью
NO177932C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive indenoindolforbindelser
ATE242768T1 (de) Herstellung und verwendung von ortho-sulfonamido bicyclische heteroaryl hydroxamsäure derivate als matrix-metalloproteinase und tace inhibitoren
PT1120415E (pt) Compostos de isoxazoliltiofeno substituido
CA2301543A1 (en) Azetidinone derivatives for the treatment of hcmv infections
BG105126A (en) Tetrahydronaphthyridinyl-carboxamides have anti-convulsant activity
DK0586298T3 (da) Inhibitor af viral herpes simplex thymidin-kinase
CA2050465A1 (en) Cyclohexenol derivatives
FI906268A (fi) 2-formylbenzylfosfonsyraderivat, deras framstaellning och deras anvaendning vid vaord av sjukdomar foerorsakade av virus.
NO940122L (no) Nye adenosinderivater
ATE210985T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
RU99124203A (ru) Цис-дизамещенные производные аминоциклоалкилпирролидина

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU